Affiliation:
1. Bristol-Myers Co., Inc., New York, New York 10022
Abstract
At equivalent oral doses, cefadroxil has a longer serum half-life, slower urinary excretion rate, greater area under the serum level versus time curve than cephalexin or cephradine, and peak serum concentrations that are 75 to 80% those of cephalexin. The calculated, apparent in vivo volume of distribution of cefadroxil is greater than that of cephalexin. These properties infer greater persistence of cefadroxil in serum and urine and more prolonged in vivo bacterial exposure to cefadroxil than to cephalexin or cephradine. Neither cefadroxil nor cephalexin demonstrates drug accumulation on repeated administration. The serum levels achieved by cefadroxil are unaffected by food. The pharmacokinetic properties of cefadroxil are supportive of the development of clinical efficacy data which could indicate that cefadroxil could be administered at 12-h intervals.
Publisher
American Society for Microbiology
Subject
Infectious Diseases,Pharmacology (medical),Pharmacology
Reference10 articles.
1. Cefadroxil, a new broad-spectrum cephalosporin;Buck R. E.;Antimicrob. Agents Chemother.,1976
2. Diem K. 1962. Documenta giegy 6th ed. p. 545. Giegy Pharmaceuticals Ardsley N.Y.
3. The two-period change-over design and its use in clinical trials;Grizzle J. E.;Biometrics,1965
4. Grove D. C. and W. A. Randall. 1953. Assay methods ofantibiotics. A laboratory manual. Medical Encyclopedia Inc. N.Y.
5. An algorithm for least-squares estimation of non-linear parameters;Marquardt D. W.;J. Soc. Ind. Appl. Math.,1963
Cited by
131 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献